6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan New Requirement

The Department of Veterans Affairs Veterans Health Administration is seeking to procure a Thyroid Cancer Molecular Test for the Orlando VA Healthcare System and Caribbean VA Healthcare System. This acquisition falls under NAICS code 621511 (Medical Laboratories) and PSC category 6640 (Laboratory Equipment and Supplies), and will be structured as a Firm-Fixed Price requirement contract. The solicitation was posted on December 10, 2025, with a planned advertisement on sam.gov around December 15, 2025, and prospective offerors must submit responses by December 29, 2025, at 4:00 PM Eastern Time. Prospective offerors must be registered in the System for Award Management (SAM) to be eligible for award. For further information and clarification on contract requirements, interested parties should contact Contracting Officer Yolanda Glover at Yolanda.Glover@va.gov. The specific evaluation criteria and detailed contract requirements will be outlined in the full solicitation document once it is published on sam.gov.

This contract opportunity is set aside exclusively for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs), making it unavailable to other business classifications. The small business size standard for this acquisition is $41.5 Million, which will determine eligibility for small business status among qualifying veteran-owned firms. No incumbent contractor or current award value has been identified in the pre-solicitation materials provided. The contract will commence upon date of award and continue through date of completion, though the specific timeline for performance and any anticipated volume requirements for thyroid cancer molecular testing have not been disclosed in this pre-solicitation notice. Interested SDVOSBs are advised to monitor sam.gov for the full solicitation release and any subsequent amendments or clarifications to ensure they maintain current information throughout the acquisition process.